| 发明名称 |
ONCOLYTIC VACCINIA VIRUS COMBINATION CANCER THERAPY |
| 摘要 |
<p>Embodiments of the invention are directed methods that include a thymidine kinase deficient vaccinia virus. The methods include evaluating a tumor for reperfusion after treatment with vaccinia virus and administering an anti-angiogenic agent if reperfusion is detected.</p> |
| 申请公布号 |
EP2477499(A1) |
申请公布日期 |
2012.07.25 |
| 申请号 |
EP20100816293 |
申请日期 |
2010.09.14 |
| 申请人 |
JENNEREX, INC. |
发明人 |
KIRN, DAVID;BREITBACH, CAROLINE |
| 分类号 |
A01N63/00;A61K48/00 |
主分类号 |
A01N63/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
